Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group

We have studied the efficacy and the prognostic impact of novel agents in 50 primary plasma cell leukemia (pPCL) patients registered in our database. Eighty percent of patients were treated upfront with novel agent-based combinations; 40% underwent autologous stem cell transplantation (ASCT). Object...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Blood Cancer J
Hlavní autoři: Katodritou, Eirini, Terpos, Evangelos, Delimpasi, Sossana, Kotsopoulou, Maria, Michalis, Eurydiki, Vadikolia, Chrysanthi, Kyrtsonis, Marie-Christine, Symeonidis, Argiris, Giannakoulas, Nikolaos, Vadikolia, Chrissa, Michael, Michalis, Kalpadakis, Christina, Gougopoulou, Theodora, Prokopiou, Chrystalla, Kaiafa, Georgia, Christoulas, Dimitrios, Gavriatopoulou, Maria, Giannopoulou, Evlampia, Labropoulou, Vasiliki, Verrou, Evgenia, Kastritis, Efstathios, Konstantinidou, Pavlina, Anagnostopoulos, Achilles, Dimopoulos, Meletios A.
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5849880/
https://ncbi.nlm.nih.gov/pubmed/29523783
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-018-0059-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky